| 000 | 01615 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513080725.0 | ||
| 264 | 0 | _c19930405 | |
| 008 | 199304s 0 0 eng d | ||
| 022 | _a0003-9950 | ||
| 024 | 7 |
_a10.1001/archopht.1993.01090030068041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuyer, D R | |
| 245 | 0 | 0 |
_aInterferon-associated retinopathy. _h[electronic resource] |
| 260 |
_bArchives of ophthalmology (Chicago, Ill. : 1960) _cMar 1993 |
||
| 300 |
_a350-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aEye Diseases _xtherapy |
| 650 | 0 | 4 |
_aEye Neoplasms _xtherapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFundus Oculi |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xadverse effects |
| 650 | 0 | 4 |
_aIschemia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRetinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aRetinal Vessels _xdrug effects |
| 650 | 0 | 4 | _aVisual Acuity |
| 700 | 1 | _aTiedeman, J | |
| 700 | 1 | _aYannuzzi, L A | |
| 700 | 1 | _aSlakter, J S | |
| 700 | 1 | _aParke, D | |
| 700 | 1 | _aKelley, J | |
| 700 | 1 | _aTang, R A | |
| 700 | 1 | _aMarmor, M | |
| 700 | 1 | _aAbrams, G | |
| 700 | 1 | _aMiller, J W | |
| 773 | 0 |
_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 111 _gno. 3 _gp. 350-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archopht.1993.01090030068041 _zAvailable from publisher's website |
| 999 |
_c8447018 _d8447018 |
||